DMAA
Drugs Made In America Acquisition Corp. Ordinary Shares
NASDAQ: DMAA · FINANCIAL SERVICES · SHELL COMPANIES
$10.53
-0.28% today
Updated 2026-04-30
Market cap
$355.55M
P/E ratio
55.50
P/S ratio
—
EPS (TTM)
$0.19
Dividend yield
—
52W range
$10 – $11
Volume
0.2M
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2024 | 2025 |
|---|---|---|
| Operating cash flow | $-172265.00 | $-539187.00 |
| Capital expenditures | $5.00 | $0.00 |
| Depreciation | — | — |
| Stock-based comp | — | — |
| Free cash flow | $-172270.00 | $-539187.00 |
| Investing cash flow | — | — |
| Financing cash flow | — | — |
| Dividends paid | — | — |
| Share repurchases | — | — |
| Debt repayment | — | — |
| Net change in cash | — | — |